Notably, TGF-β signaling has been shown to suppress migration and metastasis in CRC, whereas, in other malignancies, it facilitates epithelial–mesenchymal transition and enhances metastatic potential [15]. The gene discussed is TGFB1; the disease is colorectal carcinoma.